Both impaired pancreatic β cell function and insulin secretion have been demonstrated in both T1DM and T2DM,while treatments targeting pancreatic β cell proliferation are currently lacking [17, 18]. The gene discussed is INS; the disease is type 1 diabetes mellitus.